Jefferies Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-107,035
Closed -$908K – 1803
2026
Q2
$908K Buy
107,035
+92,035
+614% +$612K 0.01% 1012
2026
Q1
$81.8K Buy
+15,000
New +$84.2K ﹤0.01% 1619
2024
Q4
– Sell
-10,203
Closed -$93.7K – 1845
2024
Q3
$93.7K Buy
+10,203
New +$84.4K ﹤0.01% 1311
2024
Q1
– Sell
-20,100
Closed -$433K – 2021
2023
Q4
$433K Buy
+20,100
New +$371K ﹤0.01% 1277
2023
Q2
– Sell
-5,401
Closed -$140K – 1999
2023
Q1
$140K Buy
+5,401
New +$145K ﹤0.01% 1398

Other funds holding TDOC

Jefferies Financial Group's TDOC Position: Q3 2026 in Review

Jefferies Financial Group sold out of Teladoc Health (TDOC) in Q3 2026, closing a stake of 107,035 shares — an estimated $908K sold.

Jefferies Financial Group first reported a position in TDOC in Q1 2023 and held it in 5 quarters. The position peaked at $908K in Q2 2026. 252 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • Jefferies Financial Group reported no remaining Teladoc Health position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 107,035 Teladoc Health shares in Q3 2026, an estimated $908K.
  • Jefferies Financial Group first reported a position in Teladoc Health in Q1 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Teladoc Health position peaked at $908K in Q2 2026.
  • 252 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.